Cargando…
A case with primary hyperaldosteronism associated with chronic kidney disease
Primary hyperaldosteronism (PA) is one of the most common causes of secondary hypertension. PA may be associated with a decline in renal function. About 20% of cases with resistant HTN eventually cause PA, so all these patients should be evaluated for PA. Herein, we present a case with drug-resistan...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693419/ https://www.ncbi.nlm.nih.gov/pubmed/34987684 http://dx.doi.org/10.1016/j.radcr.2021.11.052 |
_version_ | 1784619138545614848 |
---|---|
author | Cadri, Vilma Rista, Elvana Toti, Florian Celep, Bahadir Shehu, Sokol Dyrmishi, Blertina Hyseni, Fjolla Ahsan, Eram Hla, Diana Guy, Ali Ikram, Samar Rahman, Abdur Tahir, Muhammad Musa, Juna |
author_facet | Cadri, Vilma Rista, Elvana Toti, Florian Celep, Bahadir Shehu, Sokol Dyrmishi, Blertina Hyseni, Fjolla Ahsan, Eram Hla, Diana Guy, Ali Ikram, Samar Rahman, Abdur Tahir, Muhammad Musa, Juna |
author_sort | Cadri, Vilma |
collection | PubMed |
description | Primary hyperaldosteronism (PA) is one of the most common causes of secondary hypertension. PA may be associated with a decline in renal function. About 20% of cases with resistant HTN eventually cause PA, so all these patients should be evaluated for PA. Herein, we present a case with drug-resistant hypertension and chronic kidney disease (CKD), the cause of which was PA. Despite his low-salt diet modifications and treatment with several classes of antihypertensive medication, he had poorly controlled blood pressure (BP). Measurements of aldosterone and renin raised the concern of PA. Imaging confirmed bilateral adrenal hyperplasia. Due to the persistently high BP, despite the modification of the antihypertensive treatment, the patient underwent unilateral adrenalectomy, as the only feasible possibility of lowering aldosterone levels. After surgery, the patient had an improvement in both BP values and renal function. PA is difficult to diagnose in patients with CKD and Arterial Hypertension because hypertension is often associated with CKD, but PA accounts for a significant percentage of drug-resistant hypertension, so these patients should be screened for secondary arterial hypertension. |
format | Online Article Text |
id | pubmed-8693419 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-86934192022-01-04 A case with primary hyperaldosteronism associated with chronic kidney disease Cadri, Vilma Rista, Elvana Toti, Florian Celep, Bahadir Shehu, Sokol Dyrmishi, Blertina Hyseni, Fjolla Ahsan, Eram Hla, Diana Guy, Ali Ikram, Samar Rahman, Abdur Tahir, Muhammad Musa, Juna Radiol Case Rep Case Report Primary hyperaldosteronism (PA) is one of the most common causes of secondary hypertension. PA may be associated with a decline in renal function. About 20% of cases with resistant HTN eventually cause PA, so all these patients should be evaluated for PA. Herein, we present a case with drug-resistant hypertension and chronic kidney disease (CKD), the cause of which was PA. Despite his low-salt diet modifications and treatment with several classes of antihypertensive medication, he had poorly controlled blood pressure (BP). Measurements of aldosterone and renin raised the concern of PA. Imaging confirmed bilateral adrenal hyperplasia. Due to the persistently high BP, despite the modification of the antihypertensive treatment, the patient underwent unilateral adrenalectomy, as the only feasible possibility of lowering aldosterone levels. After surgery, the patient had an improvement in both BP values and renal function. PA is difficult to diagnose in patients with CKD and Arterial Hypertension because hypertension is often associated with CKD, but PA accounts for a significant percentage of drug-resistant hypertension, so these patients should be screened for secondary arterial hypertension. Elsevier 2021-12-16 /pmc/articles/PMC8693419/ /pubmed/34987684 http://dx.doi.org/10.1016/j.radcr.2021.11.052 Text en © 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Cadri, Vilma Rista, Elvana Toti, Florian Celep, Bahadir Shehu, Sokol Dyrmishi, Blertina Hyseni, Fjolla Ahsan, Eram Hla, Diana Guy, Ali Ikram, Samar Rahman, Abdur Tahir, Muhammad Musa, Juna A case with primary hyperaldosteronism associated with chronic kidney disease |
title | A case with primary hyperaldosteronism associated with chronic kidney disease |
title_full | A case with primary hyperaldosteronism associated with chronic kidney disease |
title_fullStr | A case with primary hyperaldosteronism associated with chronic kidney disease |
title_full_unstemmed | A case with primary hyperaldosteronism associated with chronic kidney disease |
title_short | A case with primary hyperaldosteronism associated with chronic kidney disease |
title_sort | case with primary hyperaldosteronism associated with chronic kidney disease |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693419/ https://www.ncbi.nlm.nih.gov/pubmed/34987684 http://dx.doi.org/10.1016/j.radcr.2021.11.052 |
work_keys_str_mv | AT cadrivilma acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT ristaelvana acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT totiflorian acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT celepbahadir acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT shehusokol acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT dyrmishiblertina acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT hysenifjolla acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT ahsaneram acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT hladiana acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT guyali acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT ikramsamar acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT rahmanabdur acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT tahirmuhammad acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT musajuna acasewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT cadrivilma casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT ristaelvana casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT totiflorian casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT celepbahadir casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT shehusokol casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT dyrmishiblertina casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT hysenifjolla casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT ahsaneram casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT hladiana casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT guyali casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT ikramsamar casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT rahmanabdur casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT tahirmuhammad casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease AT musajuna casewithprimaryhyperaldosteronismassociatedwithchronickidneydisease |